Orifarm Generics' market

One stop access to the Nordic Markets
Orifarm Generics is present in all of the Nordic markets. This means that we as buyers are able to place large orders with our suppliers and draw on synergies between the markets.

In other words, our suppliers gain one stop access to four attractive markets:

• Denmark - Total market value: € 1,3 bill, accounts for 40% of total pharmaceutical market
• Sweden - Total market value: € 2,8 bill
• Norway - Total market value: € 1,2 bill
• Finland - Implementation of generic substitution in Finland on 1st of March 2003

New markets
We are currently developing a strong pipeline in Switzerland and together with our parallel imported product portfolio we will have excellent access to this interesting market. In Germany we have recently become the fourth largest parallel importer and although we are not supplying generics to this market, we are looking into the opportunities.